Table of Contents

Abnormal Regenerative Responses and Impaired Axonal Outgrowth after Nerve Crush in TDP-43 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis

  1. Jean-Pierre Julien
  1. Research Centre of CHU of Quebec, Department of Psychiatry and Neuroscience of Laval University, Quebec, Quebec G1V 4G2, Canada
  1. Author contributions: V.S., J.-N.A., D.P., J.K., and J.-P.J. designed research; V.S., J.-N.A., and D.P. performed research; V.S., J.-N.A., D.P., J.K., and J.-P.J. analyzed data; V.S., J.-N.A., J.K., and J.-P.J. wrote the paper.

  2. ↵*V.S. and J.-N.A. contributed equally to this work.

Abstract

Tar DNA binding protein 43 (TDP-43) mislocalization and aggregation is a hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia. Moreover, TDP-43 mRNA was found to be upregulated by ∼2.5-fold in the spinal cord of sporadic ALS subjects. Here we have examined the effects of nerve injury in new transgenic mouse models overexpressing by approximately threefold wild-type or mutant (G348C) TDP-43 species. Four weeks after axonal crush of sciatic nerve, TDP-43 transgenic mice remained paralyzed at the injured limb unlike control mice, which had regained most of their normal mobility. In contrast to normal mice, TDP-43 transgenic mice exhibited sustained elevation of TDP-43 cytoplasmic levels in motor neurons after nerve crush, and the relocalization of TDP-43 to the nucleus was delayed by several weeks. After crush, peripherin and ubiquitin levels remained also significantly elevated in TDP-43 transgenic mice compared with control mice. Analysis of the sciatic nerve at 11 d after nerve crush showed that the number of regenerating axons in the distal portion of the lesion was considerably reduced in TDP-43 transgenic mice, especially in TDP-43G348C mice, which exhibited a reduction of ∼40%. In addition, markers of neuroinflammation were detected at much higher levels in TDP-43 transgenic mice. These results suggest that a deregulation of TDP-43 expression in ALS is a phenomenon that can affect the regenerative responses to neuronal injury and regrowth potential of axons.

  • Received May 10, 2012.
  • Revision received October 26, 2012.
  • Accepted November 2, 2012.